Insider · CIK 0001802970
Debra Durso-Bumpus
Files at BPMC (Blueprint Medicines Corp). First filing Mar 7, 2025, latest Mar 7, 2025.
In brief
Debra Durso-Bumpus files SEC Form 4 as officer at BPMC (Blueprint Medicines Corp). Since Mar 7, 2025, Debra Durso-Bumpus has reported 0 open-market buys worth $0 and 1 open-market sell worth $458k, the latest filed on Mar 7, 2025.
A track record needs three past buys with six months of prices behind them; Debra Durso-Bumpus has 0, so none is measured yet.
The newest scored trade: sold $458k of BPMC on Mar 5, 2025, filed Mar 7, 2025, scored 47 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | Blueprint Medicines Corp | $458k 5,157 shares | -9% | - |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Common Stock | +21,353 | - | - | 70,959 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Common Stock | -51,103 | - | - | 19,856 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | UTender of shares Common Stock | -19,856 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,367 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,500 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -21,125 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -26,125 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -22,000 | - | - | 0 | Jul 21, 2025 |
| Mar 5, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock | -5,157 | $88.80 | $458k | 49,606 | Mar 7, 2025 |
| Mar 1, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Common Stock | +11,000 | $0.00 | $0 | 54,763 | Mar 4, 2025 |
| Mar 1, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Stock Option (Right to Buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Mar 4, 2025 |
Questions about Debra Durso-Bumpus
Answered from the filings on this page, as of the latest one.
Is Debra Durso-Bumpus buying or selling?
Not in the last 12 months. Debra Durso-Bumpus's latest open-market trade on SEC Form 4 was sold $458k of BPMC on Mar 5, 2025.
How did Debra Durso-Bumpus's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Debra Durso-Bumpus has 0.
Where does Debra Durso-Bumpus file Form 4?
Debra Durso-Bumpus has filed Form 4 at BPMC (Blueprint Medicines Corp) as Chief People Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.